JP Morgan Private Wealth Advisors’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Other funds holding NVCR
NA
JP Morgan Private Wealth Advisors's NVCR Position: Q1 2023 in Review
JP Morgan Private Wealth Advisors sold out of NovoCure (NVCR) in Q1 2023, closing a stake of 3,352 shares — an estimated $246K sold.
JP Morgan Private Wealth Advisors first reported a position in NVCR in Q3 2018 and held it in 14 quarters. The position peaked at $1.61M in Q3 2018. 295 funds tracked by Wall St. Rank hold NVCR as of Q1 2023.
- JP Morgan Private Wealth Advisors reported no remaining NovoCure position as of Q1 2023 after selling out during the quarter.
- JP Morgan Private Wealth Advisors sold 3,352 NovoCure shares in Q1 2023, an estimated $246K.
- JP Morgan Private Wealth Advisors first reported a position in NovoCure in Q3 2018 and held it in 14 quarters.
- JP Morgan Private Wealth Advisors's NovoCure position peaked at $1.61M in Q3 2018.
- 295 funds tracked by Wall St. Rank held NovoCure as of Q1 2023.
Based on JP Morgan Private Wealth Advisors's 13F filing for Q1 2023, filed 12 May 2023.